Literature DB >> 32253444

A "Neuromuscular Look" to sarcopenia: Is it a movement disorder?

Murat Kara1, Levent Özçakar, Bayram Kaymak, Ayşe Merve Ata, Walter Frontera.   

Abstract

OBJECTIVE: Impairment of physical function is the main determinant of morbidity/mortality in sarcopenia and frailty. Physical function tests are performed by the movement around the joints, and skeletal muscles are the main generators of the forces required to perform these functional tasks. However, the central nervous system, which initiates and coordinates muscle movements, controls the magnitude and temporal parameters of muscle forces.
METHODS: Non-systematic literature review was performed about the effects of aging on neuromotor control. RESULT: The ability of a muscle to produce force by aging is deteriorated not only by muscle structural changes, but also by neuromotor control dysfunction. With aging, changes in muscle structure and loss of volumes in brain structures related with movement and cognition have been shown. Age-related cognitive impairment can have considerable negative effects on the force generating capacity of skeletal muscles. In this sense, the relationship has been found between handgrip strength, gait speed, and cognition.
CONCLUSION: Treatments targeting muscle mass only would be insufficient unless we address the impairment of neurocognitive functions. It is essential that prescribing life-long exercise is important for healthy aging including the preservation of muscle mass/strength, physical and cognitive functioning, and independent living.

Entities:  

Keywords:  cognitive impairment; physical function; sarcopaenia

Year:  2020        PMID: 32253444     DOI: 10.2340/16501977-2672

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  8 in total

Review 1.  Rewinding sarcopenia: a narrative review on the renin-angiotensin system.

Authors:  Timur Ekiz; Murat Kara; Ayşe Merve Ata; Vincenzo Ricci; Özgür Kara; Fırat Özcan; Levent Özçakar
Journal:  Aging Clin Exp Res       Date:  2021-01-04       Impact factor: 3.636

2.  Letter to the editor concerning "Handgrip strength correlates with walking in lumbar spinal stenosis" by Inoue H, et al. (Eur Spine J 2020; 29: 2198-204).

Authors:  Sarah Razaq; Murat Kara; Levent Özçakar
Journal:  Eur Spine J       Date:  2021-03-22       Impact factor: 3.134

Review 3.  Sarcopenia and nervous system disorders.

Authors:  Jie Yang; Feifei Jiang; Ming Yang; Zhizhi Chen
Journal:  J Neurol       Date:  2022-07-13       Impact factor: 6.682

4.  Homing in on cognition with cross-sectional analysis of sarcopenia-related measurements: the SARCOG study.

Authors:  Özgür Kara; Murat Kara; Bayram Kaymak; Tuğçe Cansu Kaya; Beyza Nur Çıtır; Mahmut Esad Durmuş; Esra Durmuşoğlu; Yahya Doğan; Tülay Tiftik; Gökhan Turan; Eda Gürçay; Pelin Analay; Hasan Ocak; Fatıma Edibe Şener; Levent Özçakar
Journal:  Aging Clin Exp Res       Date:  2022-05-18       Impact factor: 4.481

5.  Longitudinal Association between Sarcopenia and Cognitive Impairment among Older Adults in Rural Malaysia.

Authors:  K Ramoo; Noran N Hairi; A Yahya; W Y Choo; F Mohd Hairi; D Peramalah; S Kandiben; A Bulgiba; Z Mohd Ali; I Abdul Razak; N Ismail; N S Ahmad
Journal:  Int J Environ Res Public Health       Date:  2022-04-14       Impact factor: 4.614

6.  The relationship between vitamin D deficiency, body composition, and physical/cognitive functions.

Authors:  Yahya Doğan; Murat Kara; Mehmet Ali Culha; Levent Özçakar; Bayram Kaymak
Journal:  Arch Osteoporos       Date:  2022-04-14       Impact factor: 2.617

Review 7.  Rehabilitation of Older Adults with Sarcopenia: From Cell to Functioning.

Authors:  Walter R Frontera
Journal:  Prog Rehabil Med       Date:  2022-09-03

8.  Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM.

Authors:  Murat Kara; Bayram Kaymak; Walter Frontera; Ayşe Merve Ata; Vincenzo Ricci; Timur Ekiz; Ke-Vin Chang; Der-Sheng Han; Xanthi Michail; Michael Quittan; Jae-Young Lim; Jonathan F Bean; Franco Franchignoni; Levent Özçakar
Journal:  J Rehabil Med       Date:  2021-06-21       Impact factor: 2.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.